AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$376M |
| 2 |
Honeywell
HON
|
+$325M |
| 3 |
Progressive
PGR
|
+$288M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$232M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLL
L3 Technologies, Inc.
LLL
|
+$529M |
| 2 |
RTX Corp
RTX
|
+$496M |
| 3 |
CVS Health
CVS
|
+$406M |
| 4 |
US Bancorp
USB
|
+$395M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$279M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.51% |
| 2 | Technology | 14.95% |
| 3 | Healthcare | 13.16% |
| 4 | Industrials | 10.42% |
| 5 | Consumer Discretionary | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Booz Allen Hamilton
BAH
$8.22B
| $204M | 0.17% |
5,646,820
-445,818
| -7% | -$15.1M |
|
127
Boeing
BA
$175B
| $201M | 0.17% |
1,289,648
-36,156
| -3% | -$5.28M |
|
128
Bloomin' Brands
BLMN
$759M
| $199M | 0.17% |
11,055,165
+1,333,420
| +14% | +$24.2M |
|
129
Eli Lilly
LLY
$1.03T
| $196M | 0.16% |
2,669,185
+949,109
| +55% | +$70.7M |
|
|
WP
130
DELISTED
Worldpay, Inc.
WP
| $196M | 0.16% |
3,284,464
-137,992
| -4% | -$7.98M |
|
131
Simon Property Group
SPG
$74.7B
| $194M | 0.16% |
1,091,125
-128,931
| -11% | -$23.9M |
|
132
Amgen
AMGN
$209B
| $193M | 0.16% |
1,322,542
-55,752
| -4% | -$8.39M |
|
133
Medtronic
MDT
$110B
| $193M | 0.16% |
2,704,235
-3,191,751
| -54% | -$251M |
|
134
Align Technology
ALGN
$12.4B
| $190M | 0.16% |
1,976,475
-849,196
| -30% | -$78.9M |
|
135
Chubb
CB
$135B
| $187M | 0.16% |
1,414,786
-14,453
| -1% | -$1.84M |
|
136
Bristol-Myers Squibb
BMY
$132B
| $185M | 0.15% |
3,172,673
-10,104
| -0.3% | -$552K |
|
137
NCR Voyix
VYX
$1.12B
| $185M | 0.15% |
7,446,075
-431,052
| -5% | -$9.68M |
|
138
AutoZone
AZO
$49.1B
| $183M | 0.15% |
232,087
+165,915
| +251% | +$128M |
|
139
Fidelity National Financial
FNF
$14B
| $182M | 0.15% |
7,714,164
+693,273
| +10% | +$16.6M |
|
140
NiSource
NI
$21.6B
| $180M | 0.15% |
8,152,054
+2,144,785
| +36% | +$47.7M |
|
|
CERN
141
DELISTED
Cerner Corp
CERN
| $180M | 0.15% |
3,798,375
+1,043,194
| +38% | +$55.4M |
|
|
RTN
142
DELISTED
Raytheon Company
RTN
| $178M | 0.15% |
1,256,544
-78,224
| -6% | -$11.1M |
|
143
Mondelez International
MDLZ
$80.5B
| $178M | 0.15% |
4,013,161
+984,014
| +32% | +$42.4M |
|
144
Qualcomm
QCOM
$160B
| $174M | 0.15% |
2,668,311
-171,208
| -6% | -$11.5M |
|
145
Liberty Global Class C
LBTYK
$3.49B
| $171M | 0.14% |
5,772,788
+604,385
| +12% | +$18.6M |
|
146
American Express
AXP
$228B
| $167M | 0.14% |
2,251,446
+80,709
| +4% | +$5.59M |
|
147
Roper Technologies
ROP
$38.5B
| $165M | 0.14% |
902,843
+400,596
| +80% | +$71.8M |
|
|
CMA
148
DELISTED
Comerica
CMA
| $165M | 0.14% |
2,424,412
+629,197
| +35% | +$36.9M |
|
149
VF Corp
VFC
$5.87B
| $163M | 0.14% |
3,253,398
+225,901
| +7% | +$11.7M |
|
150
First American
FAF
$7.71B
| $162M | 0.14% |
4,431,049
-671,122
| -13% | -$25.7M |
|
Similar funds
AllianceBernstein's Q4 2016 Portfolio in Review
As of Q4 2016, AllianceBernstein held 3,102 positions worth $120B, up 1.3% from $118B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AllianceBernstein's Q4 2016 filing shows 125 new, 894 increased, 1,362 reduced and 90 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M. The largest sale was L3 Technologies, Inc., an estimated $529M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- AllianceBernstein's largest Q4 2016 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 754,842 shares worth $83.2M.
- AllianceBernstein added most to Edwards Lifesciences in Q4 2016, an estimated $376M increase.
- AllianceBernstein's biggest Q4 2016 reduction was L3 Technologies, Inc., cutting an estimated $529M.
- AllianceBernstein fully exited Amsurg Corp in Q4 2016, selling an estimated $89.6M.
- AllianceBernstein's ten largest holdings make up 14% of its $120B portfolio in Q4 2016.
- AllianceBernstein opened 125 new positions and closed 90 in Q4 2016.
- AllianceBernstein's portfolio value rose 1.3% quarter-over-quarter to $120B.
Based on AllianceBernstein's 13F filing for Q4 2016, filed 13 Feb 2017.